Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cue Biopharma, Inc. | CHIEF FINANCIAL OFFICER | Stock Option (right to buy) | 60K | Jun 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CUE | Cue Biopharma, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | CHIEF FINANCIAL OFFICER |
CUE | Cue Biopharma, Inc. | Mar 6, 2024 | 1 | $0 | 4 | Mar 8, 2024 | CHIEF FINANCIAL OFFICER |
CUE | Cue Biopharma, Inc. | Jul 21, 2023 | 1 | $0 | 4 | Jul 25, 2023 | CHIEF FINANCIAL OFFICER |
CUE | Cue Biopharma, Inc. | Feb 16, 2023 | 1 | $0 | 4 | Feb 21, 2023 | CHIEF FINANCIAL OFFICER |
CUE | Cue Biopharma, Inc. | Aug 21, 2022 | 3 | -$8.63K | 4 | Aug 23, 2022 | CHIEF FINANCIAL OFFICER |
CUE | Cue Biopharma, Inc. | Feb 9, 2022 | 2 | $0 | 4 | Mar 29, 2022 | CHIEF FINANCIAL OFFICER |
CUE | Cue Biopharma, Inc. | Aug 23, 2021 | 6 | -$8.4K | 4 | Oct 5, 2021 | CHIEF FINANCIAL OFFICER |